FSSNX | GCSCX | FSSNX / GCSCX | |
Total Expense Ratio | 0.03 | 1.95 | 1% |
Annual Report Gross Expense Ratio | 0.03 | 2.04 | 1% |
Fund Existence | 14 years | 28 years | - |
Gain YTD | 7.442 | 8.132 | 92% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 1000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 25.9B | 488M | 5,307% |
Annual Yield % from dividends | 0.90 | 0.50 | 181% |
Returns for 1 year | 10.13 | -5.05 | -200% |
Returns for 3 years | 32.30 | 23.32 | 138% |
Returns for 5 years | 57.15 | 3.96 | 1,441% |
Returns for 10 years | 101.95 | 30.24 | 337% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
IVLU | 35.04 | 0.14 | +0.40% |
iShares Edge MSCI Intl Value Factor ETF | |||
ABXB | 19.76 | 0.05 | +0.26% |
Abacus Flexible Bond Leaders ETF | |||
DFEB | 45.89 | 0.06 | +0.13% |
FT Vest US Equity Deep Bffr ETF Feb | |||
BAMD | 31.53 | -0.16 | -0.50% |
Brookstone Dividend Stock ETF | |||
FTXH | 27.59 | -0.16 | -0.58% |
First Trust Nasdaq Pharmaceuticals ETF |